InnoCan Pharma Corporation (CSE:INNO)

InnoCan Pharma Revenue

InnoCan Pharma had revenue of $5.25M USD in the quarter ending June 30, 2026, a decrease of -25.06%. This brings the company's total for the last twelve months to $23.53M, down -18.39% year-over-year. In the year 2025, InnoCan Pharma had annual revenue of $26.61M, down -9.60%. That makes InnoCan Pharma the 32,735th largest company in the world by revenue and 585th in Canada.

• Revenue (ttm): $23.53M
• Revenue Growth: -18.39%
• P/S Ratio: 0.27
• Revenue / Employee: $4.71M
• Employees: 5
• Market Cap: 9.02M CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Online Sales 26.60M 99.9%
• Other Operations 15.00K 0.1%

By Geography

Chart

• United States 26.60M 99.9%
• Rest of The World 15.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full InnoCan Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	26.61M	-2.83M	-9.60%
Dec 31, 2024	29.44M	15.78M	115.55%
Dec 31, 2023	13.66M	11.10M	433.69%
Dec 31, 2022	2.56M	2.36M	1,205.61%
Dec 31, 2021	196.00K	188.00K	2,350.00%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error